An T, Lee J, Shin M, Yoo K, Hwang Y, Min K
BMC Pulm Med. 2024; 24(1):474.
PMID: 39334189
PMC: 11437968.
DOI: 10.1186/s12890-024-03298-x.
Maurat E, Raasch K, Leipold A, Henrot P, Zysman M, Prevel R
Eur Respir J. 2024; 64(6).
PMID: 39231631
PMC: 11627163.
DOI: 10.1183/13993003.00562-2024.
Soni S, Antonescu L, Ro K, Horowitz J, Mebratu Y, Nho R
Am J Pathol. 2024; 194(10):1807-1822.
PMID: 39032604
PMC: 11423761.
DOI: 10.1016/j.ajpath.2024.06.004.
Erice P, Huang X, Seasock M, Robertson M, Tung H, Perez-Negron M
Elife. 2024; 13.
PMID: 38722677
PMC: 11081633.
DOI: 10.7554/eLife.92879.
Wiseman D, Thwaites R, Ritchie A, Finney L, Macleod M, Kamal F
Am J Respir Crit Care Med. 2024; 210(8):994-1001.
PMID: 38502541
PMC: 11531101.
DOI: 10.1164/rccm.202308-1320OC.
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus.
Miah M, Davis A, Hannoun C, Said J, Fitzek M, Preston M
Antimicrob Agents Chemother. 2024; 68(3):e0106423.
PMID: 38349161
PMC: 10916396.
DOI: 10.1128/aac.01064-23.
Genomic attributes of airway commensal bacteria and mucosa.
Cuthbertson L, Lober U, Ish-Horowicz J, McBrien C, Churchward C, Parker J
Commun Biol. 2024; 7(1):171.
PMID: 38347162
PMC: 10861553.
DOI: 10.1038/s42003-024-05840-3.
Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease.
Jo Y, Han S, Lee D, Min K, Park S, Yoon H
Sci Rep. 2023; 13(1):18669.
PMID: 37907619
PMC: 10618439.
DOI: 10.1038/s41598-023-45835-4.
Downregulation of miRNA promotes Tc17 differentiation and emphysema via de-repression of RORγt.
Erice P, Huang X, Seasock M, Robertson M, Tung H, Perez-Negron M
bioRxiv. 2023; .
PMID: 37905101
PMC: 10614797.
DOI: 10.1101/2023.10.12.562059.
Low human beta-defensin-2 levels in the sputum of COPD patients are associated with the risk of exacerbations.
Feng S, Yang Y, Wang F, Shi W, Xu J, Tang G
BMC Pulm Med. 2023; 23(1):106.
PMID: 37003996
PMC: 10064533.
DOI: 10.1186/s12890-023-02364-0.
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections.
Tal-Singer R, Miller B, Rommes J, Luttmann M, Demaison C, Drummond M
J Patient Exp. 2023; 10:23743735231151554.
PMID: 36741822
PMC: 9893385.
DOI: 10.1177/23743735231151554.
BRD4 is involved in viral exacerbation of chronic obstructive pulmonary disease.
Duan Y, Zhou S, Wang J
Respir Res. 2023; 24(1):37.
PMID: 36721187
PMC: 9887738.
DOI: 10.1186/s12931-023-02348-y.
Nontubercular bacterial and fungal infections in patients of chronic obstructive pulmonary disease.
Khandelwal A, Chaudhary S, Verma A, Sawlani K, Gupta K, Himanshu D
Ann Afr Med. 2023; 22(1):77-81.
PMID: 36695226
PMC: 10064893.
DOI: 10.4103/aam.aam_186_21.
Persistent Steroid Exposure Before Coronavirus Disease 2019 Diagnosis and Risk of Hospitalization in Patients With Chronic Obstructive Pulmonary Disease.
Myers L, Murray R, Donato B, Liu V, Kipnis P, Shaikh A
Chronic Obstr Pulm Dis. 2022; 10(1):64-76.
PMID: 36472621
PMC: 9995236.
DOI: 10.15326/jcopdf.2022.0351.
Respiratory Viral and Bacterial Exacerbations of COPD-The Role of the Airway Epithelium.
Love M, Proud D
Cells. 2022; 11(9).
PMID: 35563722
PMC: 9099594.
DOI: 10.3390/cells11091416.
Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.
Shukla S, Shastri M, Vanka S, Jha N, Dureja H, Gupta G
Inflammopharmacology. 2022; 30(3):725-735.
PMID: 35316427
PMC: 8938636.
DOI: 10.1007/s10787-022-00968-2.
A Pandemic Lesson for Global Lung Diseases: Exacerbations Are Preventable.
Cookson W, Moffatt M, Rapeport G, Quint J
Am J Respir Crit Care Med. 2022; 205(11):1271-1280.
PMID: 35192447
PMC: 9873111.
DOI: 10.1164/rccm.202110-2389CI.
No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza.
Studer S, Rassouli F, Waldeck F, Brutsche M, Baty F, Albrich W
Infection. 2022; 50(3):699-707.
PMID: 35091985
PMC: 8799421.
DOI: 10.1007/s15010-021-01743-1.
Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people.
Snape N, Anderson G, Irving L, Jarnicki A, Hurt A, Collins T
NPJ Vaccines. 2022; 7(1):8.
PMID: 35075113
PMC: 8786852.
DOI: 10.1038/s41541-021-00422-4.
Translational Modeling of Chloroquine and Hydroxychloroquine Dosimetry in Human Airways for Treating Viral Respiratory Infections.
Kolli A, Calvino-Martin F, Hoeng J
Pharm Res. 2022; 39(1):57-73.
PMID: 35000036
PMC: 8742698.
DOI: 10.1007/s11095-021-03152-3.